California Bans Genetic Underwriting in Insurance Policies

The legislation arrives after a sustained lobbying campaign led by the ALS Association, alongside Assemblymember Lori D. Wilson and Insurance Commissioner Ricardo Lara. Proponents argued that patients frequently avoided necessary genetic screenings for fear that results could jeopardize their financial security. By prohibiting insurers from leveraging DNA data for underwriting, the state aims to remove the barrier between clinical necessity and personal risk assessment.

"No one should have to choose between their physical health and their financial future," said Assemblywoman Wilson, who championed the bill against strong opposition from the life insurance industry. For those living with progressive conditions like ALS, the statute ensures that genetic insights—vital for clinical trials and treatment planning—can be utilized without the threat of discriminatory pricing or coverage denials. Melanie Lendnal, executive vice president of the ALS Association, characterized the move as a blueprint for national policy, signaling a shift in how genetic privacy is treated within the American insurance landscape.